IP Library Granted Patent US 8,389,003
Granted Patent B2
US 8,389,003 · App. 12/294,659 · Granted Mar 5, 2013

Ingestible implement for weight control

Inventors: Martin Pavlov Mintchev (Calgary, CA); Orly Yadid-Pecht (Haifa, IL); Michel Fattouche (Calgary, CA)
Assignee: Eatlittle Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,389,003
App. No.
12/294,659
Granted
Mar 5, 2013
Kind
B2
Abstract

An orally administrable implement for expanding in a stomach of an animal, including a mammal, to fill a space in the stomach, is provided for weight control. The implement includes: a fluid-permeable expandable container having a first dimension and a second dimension; and a plurality of clusters comprising a swellable material contained within the container and capable of swelling when contacted with a fluid; whereby when the implement is ingested, the fluid in the stomach enters the container causing the clusters therein to swell and the container to expand from the first dimension to the second dimension.

Claims (22)

1. An orally administrable implement for expanding in a stomach of an animal, including a mammal, to fill a space in the stomach, comprising:

(a) a carrier;

(b) at least one fluid-permeable expandable container having a first size and a second size;

(c) a plurality of clusters contained within each container, each cluster comprising a swellable material and each cluster being capable of swelling when contacted with a fluid to expand each container from a first size to a second size; and

(d) a coupler for releasably coupling the at least one expandable container to the carrier;

whereby after a desired amount of time the plurality of clusters are individually released from each container in the stomach to now pass through the pylorus.

2. The orally administrable implement as claimed in claim 1 , wherein when the at least one container is in has the first dimension size the orally administrable implement can be retained in an ingestible capsule.

3. The orally administrable implement as claimed in claim 1 , wherein when the at least one container has the second size the implement will be of a sufficiently large size so as to be retained in the stomach.

4. The orally administrable implement as claimed in claim 1 , wherein the coupler comprises a piece of absorbable biodegradable fiber or medical gauze for releasably attaching the at least one container to the carrier.

5. The orally administrable implement as claimed in claim 1 , further comprising a built-in microelectronic system operably associated with the carrier, or the container, or both, for tracking the release of the at least one container.

6. The orally administrable implement as claimed in claim 1 , further comprising a built-in microelectronic system operably associated with the carrier, or the container, or both, for tracking the animal including a mammal that has ingested the said implement.

7. The orally administrable implement as claimed in claim 1 further comprising at least one active agent releasably associated with either the at least one container, the clusters of swellable material, or both.

8. The orally administrable implement as claimed in claim 7 , the at least one active agent is selected from the group consisting of enzymatic agents, medicinal agents, chemical agents, or combinations thereof.

9. The orally administrable implement as claimed in claim 1 , further comprising a plurality of clusters comprising a substance-absorbable material contained within the at least one container and capable of absorbing the targeted substance present in the stomach.

10. The orally administrable implement as claimed in claim 9 , wherein the substance-absorbing material is a lipid-absorbing material.

11. The orally administrable implement as claimed in claim 10 , wherein the lipid-absorbing material is lipid-absorbing chitosan fiber, oxidized cellulose fiber, or a combination of both.

12. The orally administrable implement as claimed in claim 1 , wherein the container is made from fiber comprising a substance-absorbing material.

13. The orally administrable implement as claimed in claim 12 , wherein the substance-absorbing material is a lipid-absorbing material.

14. The orally administrable implement as claimed in claim 13 , wherein the lipid-absorbing material is lipid-absorbing chitosan fiber, oxidized cellulose fiber, or a combination of both.

15. The orally administrable implement as claimed in claim 1 , wherein the implement can be self-administrable in the case of humans or administrable autonomously.

16. The orally administrable implement as claimed in claim 1 , wherein the swelled clusters do not exceed about 1.0 cm in diameter.

17. The orally administrable implement as claimed in claim 1 , wherein the swelled clusters do not exceed about 0.6 cm in diameter.

Assignments (2)
CHANGE OF NAME Recorded Jan 26, 2012
From: ELECTRONIC DIETARY FOODS INC.
To: EATLITTLE INC.
Reel/Frame 027606/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2009
From: MINTCHEV, MARTIN PAVLOV; YADID-PECHT, ORLY; FATTOUCHE, MICHEL
To: ELECTRONIC DIETARY FOODS INC.
Reel/Frame 022125/0425 →
Continuity (7)
Provisional Application 60743883 · Mar 29, 2006
Provisional Application 60788077 · Apr 3, 2006
Provisional Application 60838324 · Aug 18, 2006
Provisional Application 60853350 · Oct 23, 2006
Provisional Application 60875194 · Dec 18, 2006
Provisional Application 60904758 · Mar 5, 2007
Related Publication 20100215732A1 · Aug 26, 2010